Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Prime Medicine's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $133.07 Mil. Prime Medicine's Total Assets for the quarter that ended in Dec. 2023 was $193.85 Mil.
The historical rank and industry rank for Prime Medicine's Equity-to-Asset or its related term are showing as below:
PRME'
s Equity-to-Asset Range Over the Past 10 Years
Min: 0.61 Med: 0.74 Max: 0.88
Current: 0.69
During the past 4 years, the highest Equity to Asset Ratio of Prime Medicine was 0.88. The lowest was 0.61. And the median was 0.74.
PRME's Equity-to-Asset is ranked better than 53.54% of 1567
companies
in the Biotechnology industry
Industry Median: 0.66
vs PRME: 0.69
Prime Medicine Equity-to-Asset Historical Data
The historical data trend for Prime Medicine's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Prime Medicine's Equity-to-Asset
For the Biotechnology subindustry, Prime Medicine's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prime Medicine's Equity-to-Asset Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Prime Medicine's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Prime Medicine's Equity-to-Asset falls into.
Prime Medicine Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Prime Medicine's Equity to Asset Ratio for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prime Medicine (NAS:PRME) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Prime Medicine Equity-to-Asset Related Terms
Thank you for viewing the detailed overview of Prime Medicine's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.
Prime Medicine (Prime Medicine) Business Description
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PRME has been successfully added to your 